Efficacy of cabozantinib (C) vs everolimus (E) in patients (pts) with advanced renal cell carcinoma (RCC) and bone metastases (mets) from the phase III METEOR study Meeting Abstract


Authors: Escudier, B. J.; Powles, T.; Motzer, R. J.; Olencki, T.; Aren, O. R.; Oudard, S.; Bracarda, S.; Tomczak, P.; Castellano, D. E.; Appleman, L. J.; Drabkin, H. A.; Vaena, D. A.; Milwee, S.; Youkstetter, J.; Choueiri, T. K.
Abstract Title: Efficacy of cabozantinib (C) vs everolimus (E) in patients (pts) with advanced renal cell carcinoma (RCC) and bone metastases (mets) from the phase III METEOR study
Meeting Title: 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 15 Suppl.
Meeting Dates: 2016 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-05-20
Start Page: 258s
Language: English
ACCESSION: WOS:000404665407131
DOI: 10.1200/JCO.2016.34.15_suppl.4558
PROVIDER: wos
Notes: Meeting Abstract: 4558 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer